Horizon Therapeutics plc to Release Third-Quarter 2020 Financial Results and Host Webcast on Nov. 2, 2020
Horizon Therapeutics plc (Nasdaq: HZNP) will announce its third-quarter 2020 financial results on November 2, 2020. A live webcast is scheduled for 8 a.m. Eastern Time to discuss the financial and operational performance. Interested parties can access the live stream and replay via the company's investor relations website.
Horizon focuses on developing medicines for rare and rheumatic diseases, aiming to provide clinically meaningful therapies through scientific expertise and compassion.
- Scheduled release of third-quarter 2020 financial results on November 2, 2020
- Live webcast to discuss financial and operational performance highlights
- None.
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its third-quarter 2020 financial results will be released on Monday, Nov. 2, 2020. Following the announcement, Horizon's management will host a live webcast at 8 a.m. Eastern Time to review the Company's financial and operating results.
The live webcast and a replay may be accessed at http://ir.horizontherapeutics.com. Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. A replay of the webcast will be available approximately two hours after the live webcast.
About Horizon
Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.
